Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Bach1 derepression is neuroprotective in a mouse model of Parkinson’s disease

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2111643118Source: DataRank Database

Bach1 derepression is neuroprotective in a mouse model of Parkinson’s disease is a research paper published in Proceedings of the National Academy of Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 82 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access82 citations

Download PDF

Cite:

Linked data & code

geo pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 7.10)OA: hybridTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Navneet Ammal Kaidery ORCID,Otis C. Attucks,Erin McDade,Dmitry M. Hushpulian ORCID,Arsen Gaisin

Live enrichment

PubMed:34737234 PMC:PMC8694049 OpenAlex:https://openalex.org/W3211210582

HHS | National Institutes of Health

Grant: NS101967

Michael J. Fox Foundation for Parkinson''''s Research

Grant: N/A

NIH HHS

Grant: S10 OD025126

NINDS NIH HHS

Grant: R01 NS101967

National Institutes of Health

Grant: 1S10OD025126-01

Orbitrap Fusion Lumos ETD Mass Spectrometer

National Institutes of Health

Grant: 1R01NS101967-01

Role of Bach1-mediated transcriptional regulation in neuroprotection

FWCI

7.10

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1073/pnas.2111643118

publisherhttps://doi.org/10.1073/pnas.2111643118

publisherhttp://www.pnas.org/syndication/doi/10.1073/pnas.2111643118

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2111643118

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34737234

Fields of Study

Whipple's Disease and InterleukinsIL-33, ST2, and ILC PathwaysFibromyalgia and Chronic Fatigue Syndrome Research03 medical and health sciences0302 clinical medicine

MeSH Terms

NeuroprotectionAgedAged, 80 and overAnimalsDisease Models, AnimalDrug Evaluation, PreclinicalFemaleHumansMaleParkinson Disease1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineCase-Control StudiesMice, KnockoutBasic-Leucine Zipper Transcription FactorsMiceRatsAntioxidant Response Elements

Keywords

NeuroprotectionDerepressionParkinson's diseaseNeuroscienceDiseaseMedicinePsychologyBiologyInternal medicineGeneticsMPTPNRF2Parkinson’s DiseaseBach1Transcriptional RepressorAged, 80 and overMaleMice, KnockoutDrug Evaluation, PreclinicalParkinson DiseaseBiological SciencesAntioxidant Response ElementsRatsDisease Models, AnimalMiceBasic-Leucine Zipper Transcription Factors1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineCase-Control StudiesAnimalsHumansFemaleAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being